“The negative outlook revision reflects widening losses at the [medical center’s] employed physician group, which were worse than budgeted projections due in part to slower-than-expected practice growth. The revision also reflects softer volumes and GRMC’s highly elevated leverage,” said S&P analyst Patrick Zagar.
The ratings agency also affirmed the “BB” rating on the medical center’s series 2015 revenue refunding and improvement bonds.
More articles on healthcare finance:
Fitch affirms ‘BB’ rating on Marietta Memorial Health System’s bonds
S&P assigns ‘AA-/A-+’ rating to Hospital Sisters Health System’s bonds
Moody’s affirms ‘Aa3’ rating on Partners HealthCare’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
